Flagship explainer
What drives CUMBERLAND PHARMACEUTICALS INC’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$2.8M | FY2025 |
| |
| Income before tax | −$2.8M | FY2025 |
|
| Operating income | −$2.8M | FY2025 |
|
| $44.5M | FY2025 |
| |
| Ending assets | $76.8M | FY2025 |
|
| Beginning assets | $75.6M | FY2024 |
|
| $24.9M | FY2025 |
| |
| $22.9M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001087294-26-000020
- SEC filingFiling detailsAccession 0001628280-25-011366